Anna Jezierski
Adjunct Professor, University of Ottawa, Ottawa, Ontario · Canada
Editorial leadership for Journal of Body Fluids
Research interests
- Pcr
- Cell Culture
- Gene Expression
- Flow Cytometry
- Immunohistochemistry
- Molecular Cell Biology
- Immunofluorescence
- Molecular Genetics
- Cell Signaling
- Protein Expression
- Rna Extraction
- Cell Line Culture
- Primary Cell Culture
- Biomedical Science
- Immunofluorescence Staining
- In Vitro Cell Culture
- Cellular Biology
- Human Cell Culture
- Medical Biotechnology
- Biomedicine
Biography
Anna Jezierski is an Adjunct Professor at the University of Ottawa, Ottawa, Ontario, Canada. Her research focuses on stem cell biology, neural differentiation, and blood-brain barrier modeling, with particular emphasis on human induced pluripotent stem cells and amniotic fluid-derived cells. She has investigated receptor-mediated transcytosis in novel blood-brain barrier models and explored the therapeutic potential of amniotic fluid cells for nervous system injury treatment. Her work encompasses epigenetic regulation of neural differentiation, gap junction formation in cortical cells, and the neuroprotective effects of GDNF-expressing cells, as well as molecular mechanisms involving Rap1, E-cadherin, RBPJ transcripts, and NOS3 in cellular self-renewal and differentiation pathways.
Selected publications
- Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22 2024
- Single-Step 3D Bioprinting of Alginate–Collagen Type I Hydrogel Fiber Rings to Promote Angiogenic Network Formation 2024
- Angiogenesis driven extracellular matrix remodeling of 3D bioprinted vascular networks 2023
- Improved Cryopreservation of Human Induced Pluripotent Stem Cell (iPSC) and iPSC-derived Neurons Using Ice-Recrystallization Inhibitors 2023
- Mouse embryonic stem cell-derived blood–brain barrier model: applicability to studying antibody triggered receptor mediated transcytosis 2023
- Application of blood brain barrier models in preclinical assessment of glioblastoma- targeting CART based immunotherapies 2022
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JBF for your work?
This journal is guided by Anna Jezierski (Adjunct Professor, University of Ottawa, Ottawa, Ontario) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.